Bank of America Reiterates Buy on Coventry Health Care, Raises PT to $42

Bank of America reiterated its Buy rating on Coventry Health Care CVH. At the same time, Bank of America raised its price target from $41 to $42. In a research report published today, Bank of America stressed a rate increase in Missouri as a reason for its decision. In the report, Bank of America states, "Missouri is implementing a rate increase effective July 1, 2011 for its annual reimbursement update, based on our discussions with industry officials (see Charts 1-3). A 5.5% boost is worth $0.06 to 2011 EPS ($0.12 annualized) versus 0% assumed in guidance. We are raising our 2011/12/13 estimates to $2.91/$3.24/$3.48 from $2.85/$3.12/$3.36 and raising our PO to $42 from $41. We continue to see upside to our estimates/guidance on conservative operating assumptions. Meanwhile, there should be further upside to numbers as CVH deploys its cash hoard (over 20% of market cap deployable in 2011)." On Thursday, Coventry Health Care closed at $34.12.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorPrice TargetAnalyst RatingsBank of AmericaCoventry Health CareHealth CareManaged Health Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!